EVOLUS, INC. Operating Lease, Liability, Noncurrent
EVOLUS, INC. (EOLS) had Operating Lease, Liability, Noncurrent of $5.49 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Noncurrent $5.49M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $5.94M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $6.37M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $6.64M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $5.49M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $5.94M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $6.37M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $6.64M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $7.04M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $6.43M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $6.75M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $7.07M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $4.79M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $4.86M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $4.81M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $4.98M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $646.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $940.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.49M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.75M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $2.01M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.26M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $2.49M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $2.71M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $2.94M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.15M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $3.34M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $3.53M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.72M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $3.89M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $4.07M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $4.15M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $29.00K 10-Q · filed 2019-05-01 | |
| 2019-01-01 | $138.00K 10-K · filed 2020-02-25 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 | $25.00K 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |